Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma
Clinical trial NCT03280667 · UNKNOWN
Trial details
- NCT number
- NCT03280667
- Sponsor
- Australian and New Zealand Urogenital and Prostate Cancer Trials Group
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-12
- Primary completion
- 2023-06-04
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.